The Kingdom of Generic Drugs
How India made essential drugs affordable — and why the fight continues.
Affordable medicine is one of modern industry’s greatest achievements—and one of its fiercest battles.
India became the pharmacy of the world by combining scientific skill, manufacturing scale and a patent system that made room for competition. This book explains how that system saved lives, why it remains contested and where legitimate concerns about quality complicate an otherwise triumphant account.
Chemistry meets patent law.
Access without easy answers.
The pharmacy of the world.
Four ways this book changes how you understand the subject.
Understand the breakthrough
See how India’s 1970 patent reforms and reverse-engineering expertise transformed access to essential medicines.
Learn how generics work
Understand active ingredients, bioequivalence and the manufacturing systems behind a lower-cost equivalent.
Follow the global conflict
Connect TRIPS, compulsory licensing and trade pressure to the prices patients and health systems ultimately pay.
Face the hard questions
Examine documented quality failures and counterfeit risks without losing sight of the industry’s public-health impact.
A closer look
India’s generic-drug industry helped make lifesaving medicine affordable across the world. Its rise was built on chemistry, industrial ambition and a 1970 patent law that changed the economics of pharmaceuticals.
Arvind R. Mehta explains how manufacturers learned to reverse-engineer medicines, why active ingredients and bioequivalence matter, and how global patent rules reshaped the industry. He also confronts the difficult questions: quality-control failures, counterfeit risks, compulsory licensing and the political pressure applied when affordable copies threaten established profits.
The result is a balanced account of a public-health achievement and the contested system behind it—essential reading for anyone interested in medicine, trade, regulation and access to treatment.
For readers interested in medicine, public health, patents, India, global trade and the real economics of access.
The industry that changed global medicine
